Physician profile
Andrew V Cichelli
NPI 1710044557
$11,698.62
in general payments reported to CMS, 2019-2025
46 companies · $2,623 in 2025
The $2,623 reported for 2025 was more than what 81% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,096 · 2020: $1,325 · 2021: $1,830 · 2022: $1,855 · 2023: $1,408 · 2024: $1,561 · 2025: $2,623.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,140 · Education: $252 · Consulting Fee: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,140.10 |
| Education | $252.05 |
| Consulting Fee | $200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,576.88 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Actelion Pharmaceuticals US, INC. | $1,314.79 | 2019-2025 | Opsumit, Uptravi, Opsynvi |
| Astrazeneca Pharmaceuticals LP | $1,111.35 | 2019-2025 | Fasenra, Airsupra, Tezspire |
| Jazz Pharmaceuticals INC. | $676.02 | 2019-2025 | Xywav |
| Insmed, INC. | $629.63 | 2019-2025 | Arikayce, Brinsupri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $602.93 | 2019-2025 | Ofev, Jascayd, Stiolto Respimat |
| Harmony Biosciences LLC | $597.03 | 2020-2024 | Wakix |
| Bayer Healthcare Pharmaceuticals INC. | $588.61 | 2019-2025 | |
| Mylan Specialty L.P. | $543.25 | 2019-2024 | Yupelri |
| Regeneron Healthcare Solutions, INC. | $522.40 | 2019-2025 | Dupixent |
| Grifols USA, LLC | $379.93 | 2020-2025 | Prolastin-C Liquid |
| United Therapeutics Corporation | $348.71 | 2019-2024 | Orenitram, Remodulin |
| Takeda Pharmaceuticals U.S.A., INC. | $318.65 | 2020-2025 | Glassia |
| Axsome Therapeutics, INC. | $293.11 | 2022-2025 | Sunosi |
| Genzyme Corporation | $226.89 | 2024-2025 |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $205.12 | 2020-2023 | Acthar |
| Merck Sharp & Dohme LLC | $201.62 | 2024-2025 | Winrevair, Capvaxive, Gardasil 9 |
| Verona Pharma, INC. | $157.88 | 2025 | Ohtuvayre |
| Janssen Pharmaceuticals, INC | $153.98 | 2019-2021 | |
| Ani Pharmaceuticals, INC. | $138.85 | 2024-2025 | Purified Cortrophin Gel |
| Avadel Cns Pharmaceuticals, LLC | $100.83 | 2023-2025 | Lumryz |
| Amgen INC. | $92.53 | 2022-2025 | Tezspire |
| Stryker Corporation | $77.89 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Flowtriever |
| Baxter Healthcare | $64.29 | 2022-2025 | Hillrom - Vest System Model 105 Home Care |
| Advanced Respiratory, INC | $58.56 | 2019-2021 | |
| Olympus America INC. | $58.01 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $54.95 | 2025 | |
| Abbvie INC. | $51.37 | 2022 | |
| Genentech USA, INC. | $51.11 | 2019 | |
| Viatris Specialty LLC | $50.92 | 2025 | Yupelri |
| Idorsia Pharmaceuticals US INC | $43.97 | 2023 | Quviviq |
| Pfizer INC. | $42.10 | 2021-2025 | |
| 3b Medical, INC. | $41.37 | 2025 | Luna |
| Medtronic, INC. | $38.54 | 2021 | |
| Vifor Pharma, INC. | $35.92 | 2024-2025 | Zemaira |
| Veran Medical Technologies, INC. | $32.32 | 2020-2021 | |
| Johnson & Johnson Health Care Systems INC. | $30.75 | 2023 | Opsumit |
| Allergan, INC. | $24.91 | 2019-2020 | |
| Mallinckrodt Enterprises LLC | $24.81 | 2019 | |
| Shionogi INC | $23.88 | 2023 | Fetroja |
| Cvrx, INC. | $21.01 | 2025 | Barostim Neo System |
| La Jolla Pharmaceutical Company | $20.42 | 2022 | |
| Electromed, INC. | $20.33 | 2025 | Smartvest |
| Lilly USA, LLC | $19.00 | 2025 | Zepbound |
| Philips North America LLC | $17.39 | 2022 | |
| Arbor Pharmaceuticals, INC. | $13.81 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Cichelli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.